HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alving, A. S. Articles by Donovan, W. N. Search for Related Content PubMed PubMed Citation Articles by Alving, A. S. Articles by Donovan, W. N.

Korean Vivax Malaria

II. Curative Treatment with Pamaquine and Primaquine^*

Fifteen milligrams of primaquine base administered daily for 14 days, in conjunction with standard chloroquine therapy (1.5 gm. base or 2.5 gm. chloroquine diphosphate in 3 days), constitutes the treatment of choice for the radical cure of Plasmodium vivax of Korean origin during late clinical activity. This therapeutic schedule may be safely continued on an ambulatory basis with only minimum medical supervision after acute symptoms have subsided.

Clinically significant toxicity was not observed with either primaquine or pamaquine, although in the dosage employed pamaquine is potentially toxic in a small percentage of Negroes.

^* These studies were conducted at Fort Knox, Kentucky and Fort Benning, Georgia. Most of the primaquine was supplied gratuitously by Eli Lilly & Co. for which thanks are extended. This work was supported (in part) by the Medical Research and Development Board, Office of the Surgeon General, Department of the Army.

¹ Department of Medicine, University of Chicago.

² First Lieut., Captain, Captain, Lt. Colonel, respectively, MC, U.S.A.

³ Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health.

⁴ Department of Medicine, University of Pennsylvania.

This article has been cited by other articles:

				G. Jun, J.-S. Yeom, J.-Y. Hong, E-H. Shin, K.-S. Chang, J.-R. Yu, S. Oh, H. Chung, and J.-W. Park Resurgence of Plasmodium vivax Malaria in the Republic of Korea during 2006-2007 Am J Trop Med Hyg, October 1, 2009; 81(4): 605 - 610. [Abstract] [Full Text] [PDF]

				J. K. Baird Resistance to Therapies for Infection by Plasmodium vivax Clin. Microbiol. Rev., July 1, 2009; 22(3): 508 - 534. [Abstract] [Full Text] [PDF]

				K. Chotivanich, J. Sattabongkot, Y. K. Choi, J. S. Park, J. Sritabal, C. S. Lim, R. Udomsangpetch, N. J. White, and W. J. Lee Antimalarial Drug Susceptibility of Plasmodium vivax in the Republic of Korea Am J Trop Med Hyg, June 1, 2009; 80(6): 902 - 904. [Abstract] [Full Text] [PDF]